Xiromed LLC secured FDA approval for JAIMIESS, the generic version of Levonorgestrel and Ethinyl Estradiol tablets, positioning the company to capture...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Sandoz Inc. has received FDA approval for its generic intravenous formulation of tigecycline, increasing therapeutic availability and competing agains...
Cranbury Pharmaceuticals, LLC secured FDA approval for its generic Morphine Sulfate oral formulation, granting the company a strategic foothold in the...
Fresenius Kabi USA, LLC has received FDA approval for glucagon hydrochloride injection (NDA 201849), enabling the company to further expand its emerge...
Lupin Pharmaceuticals, Inc. received FDA approval for its Abbreviated New Drug Application #ANDA204603 to manufacture Oxycodone Hydrochloride on April...
U.S. regulators approved AbbVie’s **Humira** (adalimumab), the biopharmaceutical giant’s best-selling therapy, bringing the blockbuster drug to market...
BluePoint Laboratories announced the approval of oral capitolabine trading on Wednesday, adding a generic alternative to the market for cancer treatme...
Sanofi has announced that its subsidiary, Actavis Elizabeth, has received final approval from the FDA for its generic drug, which is expected to竞争扩大该产...
Fresenius Kabi USA announced its submission of an NDA for [Substance] on March 23, 2015, signaling a strategic move aimed at diversifying its portfoli...
QUAGEN announced FDA approval of its generic product and expects it to capture market share by providing a cost-effective alternative to the branded v...
Actavis Pharma has received approval for the ANDA090819 filing, expanding its portfolio with this generic sublingual buprenorphine HCl product, a form...
On February 13, 2015, Eisai Inc. received an FDA approval for a new drug application (NDA 206947), a development that is poised to significantly impac...
Pfizer received FDA approval for the oral breast cancer therapy Palbociclib (IBRANCE) on February 3, 2015, marking a significant entry into the rapidl...
Novartis Pharmaceuticals received FDA approval for Secukinumab (Cosentyx) on Jan. 21, 2015, a strategic milestone expected to bolster the company’s po...
Zydus Pharmaceuticals USA Inc. secured FDA approval for Carbidopa and Levodopa, providing a new oral generic option into the high-volume central nervo...
Teva Pharmaceutical received FDA approval for its Abbreviated New Drug Application (ANDA 202718) on December 29, 2014, enabling the generic launch of ...
Novo Nordisk Pharmaceutical Industries, LP received FDA approval for Saxenda (liraglutide) in 2014, a GLP-1 agonist that entered the market to address...
The FDA has approved Opdivo (nivolumab) from E.R. Squibb & Sons, L.L.C., a key asset for the manufacturer's oncology franchise that is poised to bolst...
Carwin Pharmaceutical Associates, LLC received FDA clearance for its potassium chloride oral formulation POKONZA, a move expected to expand generic su...
# FDA Approves Merck's ZERBAXA (Ceftolozane and Tazobactam) for Serious Bacterial Infections The FDA has approved Merck Sharp & Dohme LLC's ZERBAXA (...